CHKB p.Pro88Leu
c.263C>T · rs146163970 · VCV447030
Computational evidence
| Protein change | ||
| AlphaMissense | 0.37 | ambiguous |
|---|---|---|
| REVEL | 0.378 | indeterminate |
| SaProt | LLR -11.96 | damaging |
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · G>T here scores Δ0.94 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 9.5 | GERP 2.2, phastCons 1 |
| Regional constraint | o/e 1.03 | unconstrained · MANE · 3,597 bp · p 0.53 · regional, not allelic |
| Overall | ||
| CADD | 29.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.363% | 276 |
| South Asiangrpmax | 0.0451% | 2,219 |
| Finnishnot grpmax-eligible | 0.0284% | 3,518 |
| Remaining individualsnot grpmax-eligible | 0.0245% | 4,081 |
| Middle Eastern | 0.0216% | 4,624 |
| European (non-Finnish) | 0.0161% | 6,209 |
| Admixed American | 0.00359% | 27,833 |
| African / African-American | 0.00269% | 37,218 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CHKB
- Protein
- p.Pro88Leu
- Coding
- c.263C>T
- MANE Select
- NM_005198
- dbSNP
- rs146163970
- Type
- single nucleotide variant
- Location
- chr22:50582319 (GRCh38)
- Gene constraint
- LOEUF 1.015 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 86.54 · 3 PDB
- Residue 88
- a UniProt-annotated variant site (in mdcmc; loss of choline kinase activity; decreased amount of phosphatidylcholine in patients cells)
Disease context
megaconial type congenital muscular dystrophy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Megaconial congenital muscular dystrophy (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- CHKB p.Pro88Ser Uncertain significance ★ ⚠ same residue
- CHKB p.Gln51Ter Pathogenic/Likely pathogenic ★★ same condition
- CHKB c.*208T>G Uncertain significance ★★ same condition
- CHKB p.Ala361Val Uncertain significance ★★ ⚠ same condition
- CHKB p.Arg344Trp Uncertain significance ★★ ⚠ same condition
- CHKB p.Arg62Cys Uncertain significance ★★ ⚠ same condition
- CHKB p.Gln309Glu Uncertain significance ★★ ⚠ same condition
- CHKB p.Glu214Asp Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/chkb-p-pro88leu (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown